Regional Analysis
Asia Pacific is the largest and estimated to be the fastest growing market due to burgeoning growth in the pharmaceutical industry, which has been driven by urbanization in India. Increase in geriatric and infant population has led to an elevated demand for medicines. Moreover, cheaper healthcare facilities in countries such as Thailand and India has boosted medical tourism in the region
Europe is estimated to be the second largest market for pyridine due to high consumption rate of pharmaceutical products and latexes. Although the pharmaceutical industry in these regions is matured, with high prevalence of lifestyle diseases, the market is projected to grow further
North America is an emerging market for pyridine derivatives. The growth of pyridine and pyridine derivative market is due to the need for productivity of agriculture field, which requires non-toxic and noble products
The Middle East population has high disposable incomes, which drives consumerism. Consumption of electronics and consumer goods are growing rapidly, driving the pyridine and pyridine derivative market as well. Decline in markets of Syria and Iran have been compensated by high growth rate in the GCC countries
Latin America plays a major role in boosting the global pyridine and pyridine derivative market growth. Brazil is the fourth largest pharmaceutical market in the world. Argentina, Mexico, and Brazil are also among the largest producers of non-patented generic drugs, which are exported to over 40 countries
Geographies covered: Asia Pacific, Europe, North America, Middle East, Latin America
U.S.: 
U.K. : 
India : 
